China Pharma Holdings (CPHI) Land & Improvements (2011 - 2023)
China Pharma Holdings (CPHI) reported Land & Improvements of $389808.0 for Q2 2023, down 7.12% on a YoY basis from $419685.0 in Q2 2022, and down 4.9% quarter-over-quarter from $409895.0 in Q1 2023.
China Pharma Holdings (CPHI) Land & Improvements (2011 - 2023) Analysis & Trends
China Pharma Holdings has reported Land & Improvements for 13 years, with the latest figure at $389808.0 in Q2 2023.
- For the quarter ending Q2 2023, Land & Improvements fell 7.12% year-over-year to $389808.0; the trailing twelve-month figure through Jun 2023 stood at $389808.0 (down 7.12% YoY), and the FY2022 full-year result was $404427.0, down 8.46% from the prior year.
- Land & Improvements for Q2 2023 stood at $389808.0, down from $409895.0 in the prior quarter.
- The five-year high for Land & Improvements was $443697.0 in Q1 2022, with the low at $389808.0 in Q2 2023.
- Historically, Land & Improvements has averaged $416443.1 across 5 years, with a median of $413603.0 in 2020.
- Annual changes were most pronounced in 2021 — Land & Improvements advanced 9.59% — and 2022, when it declined 8.65%.
- China Pharma Holdings' Land & Improvements stood at $403755.0 in 2019, then rose by 6.92% to $431681.0 in 2020, then gained by 2.34% to $441783.0 in 2021, then declined by 8.46% to $404427.0 in 2022, then decreased by 3.61% to $389808.0 in 2023.
- The last three Land & Improvements figures came in at $389808.0 (Q2 2023), $409895.0 (Q1 2023), and $404427.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 389,808.00 |
| Mar 31, 2023 | 409,895.00 |
| Dec 31, 2022 | 404,427.00 |
| Sep 30, 2022 | 396,726.00 |
| Jun 30, 2022 | 419,685.00 |
| Mar 31, 2022 | 443,697.00 |
| Dec 31, 2021 | 441,783.00 |
| Sep 30, 2021 | 434,310.00 |
| Jun 30, 2021 | 436,011.00 |
| Dec 31, 2020 | 431,681.00 |
| Sep 30, 2020 | 413,603.00 |
| Jun 30, 2020 | 397,864.00 |
| Mar 31, 2020 | 428,633.00 |
| Dec 31, 2019 | 403,755.00 |
| Sep 30, 2019 | 398,235.00 |
| Jun 30, 2019 | 409,716.00 |
| Mar 31, 2019 | 419,703.00 |
| Dec 31, 2018 | 409,612.00 |
| Sep 30, 2018 | 410,203.00 |
| Jun 30, 2018 | 425,541.00 |